Related Experiment Video
Updated: Jun 18, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
[Research progress on DNMT3A gene expression in Acute myeloid leukemia]
Jiawei Zhou1, Tao Wu, Wenhui Liu
1940th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Lanzhou, Gansu 730050, China. wutaozhen@yeah.net.
Abstract:
DNA methylation is an important epigenetic regulatory mechanism which plays a crucial role in cell differentiation and development. Its function is closely related to DNA methyltransferase 3 alpha (DNMT3A), which can affect gene expression and stem cell differentiation. The mutation rate of the DNMT3A gene is relatively high in Acute myeloid leukemia (AML), but its type and pathogenic mechanism are not yet clear. Further research on DNMT3A may help to identify its pathogenic targets and provide a basis for precise treatment of AML. This article has provided a review for the research progress on the expression of the DNMT3A gene in AML.

